Logo

Suven Pharma Share Price

Suven Pharma (INR)1061.95-42.1   (-3.8%)

Exchange ScripsBSE543064NSESUVENPHARISININE03QK01018

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Suven Pharma Performance

Market performance
Open price1106.95
High1107
Volumes194760
Prev Close1061.95
Low1056
Closing date2025-01-10
Historical performance
1 Year High1360.00
3 Year High1360.00
5 Year High1360.00
1 Year Low585.20
3 Year Low390.50
5 Year Low87.60

Suven Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
26993
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
90.03
Dividend Yield
Dividend Yield
N/A

Suven Pharma Investment Returns

1 Year
44.6%
3 Years
115.1%
5 Years
N/A
10 Years
N/A

Suven Pharma Technicals

IndicatorsValueSignal
5-DMA1090.22Bearish
10-DMA1107.2Bearish
20-DMA1154.35Bearish
50-DMA1235.4Bearish
100-DMA1204.17Bearish
200-DMA974Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters11177
Foreign Investors11111
Domestic Investors---------66
Public Investors6933665776689317004573708
Government11111

Suven Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income619464924142
Operating Profit4677620567414572
Interest7512885117
Depreciation546480391316
Profit Before Tax4057559766764677
Consolidated Net Profit3003411345383623
Adjusted EPS12161814

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital255255255255
Total Reserves20232170971501711554
Minority Interest------------
Total Non-Current Liabilities965718921739
Total Liabilities23532211011966815762
Capital Work in Progress17901651300961
Total Assets23532211011966815762

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities3585457233003825
Cash Flow from Investing Activities-3623-1950-1361-3114
Cash Flow from Financing Activitie-138-2420-1565-757
Net Cash Inflow / Outflow-176202374-45
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 90.03.
  • 3Y Stock Price CAGR of the stock is 24.6.
  • The stock has a beta of 0.4.
  • In the last financial year, the company had an EBITDA of ₹4677 Million.
  • The company generated revenue of ₹10514 Million in the previous financial year.

Suven Pharma

1061.95-42.1   (-3.8%)

Investment Amount: ₹ 70305
Current Value: ₹ 106195
Performance: 51%
P/L: ₹ 35890
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month